NEUROPHET, Inc. (KOSDAQ:380550)
South Korea
· Delayed Price · Currency is KRW
20,700
-300 (-1.43%)
Apr 29, 2026, 3:30 PM KST
NEUROPHET Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 253,929 | 258,914 | - |
| Last Close Price | 21000.00 | 22250.00 | - |
| PS Ratio | 97.10 | 99.01 | - |
| PB Ratio | 13.05 | 13.31 | - |
| P/TBV Ratio | 13.35 | 13.61 | - |
| Debt / Equity Ratio | 0.28 | 0.28 | -0.18 |
| Net Debt / Equity Ratio | -0.94 | -0.94 | 0.05 |
| Net Debt / EBITDA Ratio | 1.18 | 1.18 | 0.09 |
| Net Debt / FCF Ratio | 1.19 | 1.19 | 0.09 |
| Asset Turnover | 0.14 | 0.14 | - |
| Inventory Turnover | 0.14 | 0.14 | - |
| Quick Ratio | 3.49 | 3.49 | 0.18 |
| Current Ratio | 3.61 | 3.61 | 0.19 |
| Return on Assets (ROA) | -56.30% | -56.30% | - |
| Return on Capital Employed (ROCE) | -83.00% | -83.00% | 57.20% |
| Earnings Yield | -8.82% | -8.65% | - |
| FCF Yield | -6.04% | -5.92% | - |
| Buyback Yield / Dilution | - | -163.48% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.